Annual non current assets:
$734.33M+$518.77M(+240.66%)Summary
- As of today (July 4, 2025), RXRX annual long term assets is $734.33 million, with the most recent change of +$518.77 million (+240.66%) on December 31, 2024.
- During the last 3 years, RXRX annual non current assets has risen by +$658.70 million (+870.99%).
- RXRX annual non current assets is now at all-time high.
Performance
RXRX Non current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly non current assets:
$721.09M-$13.24M(-1.80%)Summary
- As of today (July 4, 2025), RXRX quarterly long term assets is $721.09 million, with the most recent change of -$13.24 million (-1.80%) on March 31, 2025.
- Over the past year, RXRX quarterly non current assets has increased by +$506.86 million (+236.59%).
- RXRX quarterly non current assets is now -1.80% below its all-time high of $734.33 million, reached on December 31, 2024.
Performance
RXRX quarterly non current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Non current assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
RXRX Non current assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +240.7% | +236.6% |
3 y3 years | +871.0% | +527.8% |
5 y5 years | +2833.4% | - |
RXRX Non current assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +871.0% | -1.8% | +469.9% |
5 y | 5-year | at high | +2833.4% | -1.8% | +2143.0% |
alltime | all time | at high | +2833.4% | -1.8% | +2143.0% |
RXRX Non current assets History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $721.09M(-1.8%) |
Dec 2024 | $714.27M(+63.0%) | $734.33M(+191.0%) |
Sep 2024 | - | $252.33M(-0.5%) |
Jun 2024 | - | $253.49M(+18.3%) |
Mar 2024 | - | $214.23M(-0.6%) |
Dec 2023 | $438.14M(-23.1%) | $215.56M(-2.2%) |
Sep 2023 | - | $220.30M(-6.5%) |
Jun 2023 | - | $235.68M(+74.3%) |
Mar 2023 | - | $135.24M(+2.9%) |
Dec 2022 | $569.81M | $131.47M(+1.2%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $129.91M(+2.7%) |
Jun 2022 | - | $126.52M(+10.1%) |
Mar 2022 | - | $114.86M(+51.9%) |
Dec 2021 | $534.72M(+100.7%) | $75.63M(+31.0%) |
Sep 2021 | - | $57.74M(+13.3%) |
Jun 2021 | - | $50.95M(+1.7%) |
Mar 2021 | - | $50.12M(+55.9%) |
Dec 2020 | $266.44M(+248.7%) | - |
Dec 2020 | - | $32.15M |
Dec 2019 | $76.40M | - |
FAQ
- What is Recursion Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual non current assets year-on-year change?
- What is Recursion Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly non current assets year-on-year change?
What is Recursion Pharmaceuticals annual long term assets?
The current annual non current assets of RXRX is $734.33M
What is the all time high annual non current assets for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual long term assets is $734.33M
What is Recursion Pharmaceuticals annual non current assets year-on-year change?
Over the past year, RXRX annual long term assets has changed by +$518.77M (+240.66%)
What is Recursion Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of RXRX is $721.09M
What is the all time high quarterly non current assets for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly long term assets is $734.33M
What is Recursion Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, RXRX quarterly long term assets has changed by +$506.86M (+236.59%)